Abstract
Optimizing utilization of sacubitril/valsartan for treatment of heart failure could improve provider performance in the Bundled Payments for Care Improvement initiative and the Medicare Shared Savings Program.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have